US 10449170
Compositions for diagnosis and treatment of type 2 diabetes
granted A61KA61K31/20
Quick answer
US patent 10449170 (Compositions for diagnosis and treatment of type 2 diabetes) held by The United States of America, as represented by Secretary of the Navy expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by Secretary of the Navy
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/20